On August 29, 2025 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, reported that senior leadership plans to present at the following conferences (Press release, Iovance Biotherapeutics, AUG 29, 2025, View Source [SID1234655584]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
2025 Wells Fargo Healthcare Conference
Fireside Chat: September 5, 2025 at 8:00 a.m. ET
Boston, MA
H.C. Wainwright 27th Annual Global Investment Conference
Presentation: September 9, 2025 at 11:00 a.m. ET
New York, NY
The live and archived webcasts will be available at View Source